STVN logo

STEVANATO GROUP SPA

STVNNYSE
๐Ÿ† #1007 by market capEarnings Nov 5US Equity
$20.84โ–ผ $0.21 (โˆ’1.02%)
Live
1hโ€”
24hโ–ผ 1.0%
7dโ–ฒ 3.0%
14dโ–ฒ 2.2%
30dโ–ฒ 5.4%
1yโ–ผ 4.3%
๐ŸฆMarket Cap
$6.31B
Small Cap
๐Ÿ“ˆRevenue Growth (YoY)
+7.0%
Slowing
๐Ÿ“ŠGross Margin
29.9%
Moderate
๐Ÿ’ตFCF Margin
0.4%
Thin
โš–๏ธP/S Ratio
4.0x
Fair
Otter Score
45
Weak

Trading Snapshot

Day Range
$20.67 โ€“ $21.01
52-Week Range
โ€”
Volume
$3.91B
Avg Volume
$4.29B
Shares Outstanding
302.8M
Next Earnings
Sep 24, 2026

Fundamentals Snapshot

Annual Revenue
$1.14B
Last Q Revenue
$302M
P/E Ratio
36.1
P/S Ratio
4.0x
EPS (TTM)
โ€”
Dividend Yield
0.30%

Why Investors Own STVN

  • โœ“High-growth profile โ€” revenue up +57.2% YoY with expanding US Equity exposure.
  • โœ“Healthy economics โ€” 66% gross margin and 11% free-cash-flow margin.
  • โœ“New products and segments could unlock additional revenue streams.
โš ๏ธ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

Financial Trends

Revenue (TTM)
$1.14Bโ–ฒ +51.4% YoY
Gross Margin (TTM)
66.3%โ–ฒ +1.4% YoY
Operating Income (TTM)
$299Mโ–ฒ +51.4% YoY
Free Cash Flow (TTM)
$126Mโ–ฒ +51.4% YoY

About STEVANATO GROUP SPA

Stevanato Group S.p.A. is dedicated to engineering, manufacturing, and distributing integrated solutions for the pharmaceutical and healthcare sectors. Its core offerings span a wide array of products, including containment solutions, drug delivery systems, and medical devices, alongside diagnostic and analytical support. The company also produces specialized machinery for tasks such as visual inspection, assembly, packaging, and glass formation. Established in 1949, the company's main operations are situated in Piombino Dese, Italy, functioning as a subsidiary of Stevanato Holding S.R.L.

๐Ÿฆฆ

Otter Score Breakdown

โ“˜
๐Ÿ’ŽQualityโ˜…โ˜…โ˜…โ˜…โ˜…
๐Ÿš€Growthโ˜…โ˜…โ˜…โ˜…โ˜…
โš–๏ธValuationโ˜…โ˜…โ˜…โ˜…โ˜…
โšกMomentumโ˜…โ˜…โ˜…โ˜…โ˜…
Overall Score
Weak
45/100

Analyst Ratings

โ“˜
Consensus
Buy
18 analysts
Strong Buy7
Buy7
Hold4
Sell0
Strong Sell0
Ratings as of Aug 2026

Latest News & Updates

Benzingaยท1d ago

Chief Financial Officer At Stevanato Group Sells $84K Of Stock

Revealing a significant insider sell on August 10, Marco Lago Dal, Chief Financial Officer at Stevanato Group (NYSE:STVN), as per the latest SEC filing. What Happened: Dal's recent Form 4 filing with the U.S.

SeekingAlphaยท7d ago

Stevanato Group S.p.A. (STVN) Q2 2026 Earnings Call Transcript

Stevanato Group S.p.A. (STVN) Q2 2026 Earnings Call August 4, 2026 8:30 AM EDTCompany ParticipantsLisa Miles - Chief Communications & Investor Relations...

Benzingaยท8d ago

Stevanato Group Q2 2026 Earnings Call: Complete Transcript

Stevanato Group (NYSE:STVN) held its second-quarter earnings conference call on Tuesday. Below is the complete transcript from the call. Benzinga APIs provide real-time access to earnings call transcripts and financial

๐Ÿš€
Benzingaยท8d ago

Stevanato Group Lowers FY2026 GAAP EPS Guidance from $0.64-$0.69 to $0.62-$0.64; Lowers FY2026 Sales Guidance from $1.467B-$1.500B to $1.465B-$1.488B

Stevanato Group (NYSE:STVN) lowers FY2026 GAAP EPS guidance from $0.64-$0.69 to $0.62-$0.64. Lowers FY2026 sales outlook from $1.467 billion-$1.500 billion to $1.465 billion-$1.488 billion.

๐Ÿ›ฐ๏ธ
Benzingaยท8d ago

Stevanato Group Narrows FY2026 Adj EPS Guidance from $0.69-$0.73 to $0.70-$0.72 vs $0.68 Est; Lowers FY2026 Sales Guidance from $1.467B-$1.500B to $1.465B-$1.488B vs $1.500B Est

Stevanato Group (NYSE:STVN) narrows FY2026 Adj EPS guidance from $0.69-$0.73 to $0.70-$0.72 vs $0.68 analyst estimate. Lowers FY2026 sales outlook from $1.467 billion-$1.500 billion to $1.465 billion-$1.488 billion vs

๐ŸŒŒ
Benzingaยท8d ago

Stevanato Gr Q2 Adj. EPS $0.16 Beats $0.14 Estimate, Sales $351.091M Miss $351.370M Estimate

Stevanato Gr (NYSE:STVN) reported quarterly earnings of $0.16 per share which beat the analyst consensus estimate of $0.14 by 14.29 percent. This is a 23.08 percent increase over earnings of $0.13 per share from the